Melanie Kripp

485 total citations
24 papers, 319 citations indexed

About

Melanie Kripp is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Melanie Kripp has authored 24 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Melanie Kripp's work include Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal and Anal Carcinomas (7 papers). Melanie Kripp is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal and Anal Carcinomas (7 papers). Melanie Kripp collaborates with scholars based in Germany, Slovenia and Portugal. Melanie Kripp's co-authors include Ralf‐Dieter Hofheinz, Andreas Hochhaus, Andreas Willer, Sabine Mai, S. Al-Batran, Dietmar Dinter, Jessica C. Hassel, Kirsten Merx, Philipp Ströbel and Stefan Post and has published in prestigious journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Melanie Kripp

24 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melanie Kripp Germany	11	159	140	100	60	36	24	319
Willemieke P.M. Dijksterhuis Netherlands	12	171 1.1×	199 1.4×	215 2.1×	40 0.7×	21 0.6×	30	463
Brooke Steele United States	6	205 1.3×	71 0.5×	51 0.5×	21 0.3×	15 0.4×	7	344
G. Pérez Manga Spain	8	233 1.5×	77 0.6×	84 0.8×	17 0.3×	22 0.6×	35	400
A Loganayagam United Kingdom	8	169 1.1×	43 0.3×	48 0.5×	23 0.4×	11 0.3×	15	288
Marc De Man Belgium	10	178 1.1×	124 0.9×	73 0.7×	71 1.2×	35 1.0×	28	321
Arielle G. Bensimon United States	12	73 0.5×	105 0.8×	49 0.5×	14 0.2×	21 0.6×	34	543
Marc Earl United States	11	137 0.9×	30 0.2×	29 0.3×	92 1.5×	73 2.0×	24	288
Yasuhiko Miura Japan	17	235 1.5×	304 2.2×	180 1.8×	99 1.6×	18 0.5×	48	642
Tehseen Salimi United States	10	87 0.5×	77 0.6×	39 0.4×	32 0.5×	10 0.3×	31	276
Ashraf Shoma Egypt	10	75 0.5×	139 1.0×	45 0.5×	16 0.3×	5 0.1×	19	313

Countries citing papers authored by Melanie Kripp

Since Specialization

Citations

This map shows the geographic impact of Melanie Kripp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Kripp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Kripp more than expected).

Fields of papers citing papers by Melanie Kripp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Kripp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Kripp. The network helps show where Melanie Kripp may publish in the future.

Co-authorship network of co-authors of Melanie Kripp

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Kripp. A scholar is included among the top collaborators of Melanie Kripp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Kripp. Melanie Kripp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaiser, Maria Rita, Sylvie Lorenzen, Kirsten Merx, et al.. (2019). Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score. Cancer Medicine. 8(9). 4169–4175. 4 indexed citations

Hofheinz, Ralf‐Dieter, Sylvie Lorenzen, Jörg Trojan, et al.. (2018). EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity. Annals of Oncology. 29(4). 1010–1015. 15 indexed citations

Merx, Kirsten, Uwe M. Martens, Melanie Kripp, et al.. (2017). Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT. International Journal of Radiation Oncology*Biology*Physics. 99(4). 867–875. 7 indexed citations

Suling, Anna, Karin Oechsle, Anja Mehnert, et al.. (2016). Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study. BMC Palliative Care. 15(1). 25–25. 9 indexed citations

Hofheinz, Ralf‐Dieter, et al.. (2016). Use of Complementary and Alternative Medicine in Cancer Patients: A Prospective Questionnaire-Based Study in an Oncological Outpatient Clinic. Oncology Research and Treatment. 39(5). 260–265. 11 indexed citations

Kripp, Melanie, et al.. (2015). Does Physical Activity Improve Quality of Life in Cancer Patients Undergoing Chemotherapy?. Oncology Research and Treatment. 38(5). 230–236. 8 indexed citations

Hofheinz, Ralf‐Dieter, Melanie Kripp, & Sylvie Lorenzen. (2015). Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!. PubMed. 7(12). E629–32. 2 indexed citations

Hartmann, Jörg T., Salah‐Eddin Al‐Batran, Melanie Kripp, et al.. (2014). Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study. Journal of Cancer Research and Clinical Oncology. 140(5). 829–837. 7 indexed citations

Kripp, Melanie, Andreas Willer, Lothar R. Pilz, et al.. (2013). Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors. Annals of Hematology. 93(2). 317–325. 23 indexed citations

10.

Kripp, Melanie, Salah‐Eddin Al‐Batran, Claudia Pauligk, et al.. (2013). Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Gastric Cancer. 17(1). 181–187. 13 indexed citations

11.

Schulte, Nadine, Sebastian Belle, Kirsten Merx, et al.. (2013). Cancer Patients and Advance Directives: A Survey of Patients in a Hematology and Oncology Outpatient Clinic. Oncology Research and Treatment. 36(7-8). 398–402. 34 indexed citations

12.

Horisberger, Karoline, et al.. (2013). Impaired continence function five years after intensified chemoradiation in patients with locally advanced rectal cancer. European Journal of Surgical Oncology. 40(2). 227–233. 13 indexed citations

13.

Kripp, Melanie, P. Kienle, Grit Welzel, et al.. (2012). Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer – impact on long-term quality of life. European Journal of Surgical Oncology. 38(6). 472–477. 16 indexed citations

14.

Hassel, Jessica C., Melanie Kripp, S. Al-Batran, & Ralf‐Dieter Hofheinz. (2010). Treatment of Epidermal Growth Factor Receptor Antagonist-Induced Skin Rash: Results of a Survey among German Oncologists. Onkologie. 33(3). 94–98. 34 indexed citations

15.

Ernst, Thomas, Melanie Kripp, Kirsten Merx, et al.. (2010). Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma. Journal of Cancer Research and Clinical Oncology. 136(12). 1845–1851. 3 indexed citations

16.

Metzgeroth, Georgia, Melanie Kripp, Nadine Müller, et al.. (2009). The soluble transferrin receptor (TfR)-F-Index is not applicable as a test for iron status in patients with chronic lymphocytic leukemia. Clinical Chemistry and Laboratory Medicine (CCLM). 47(10). 1291–5. 7 indexed citations

17.

Ströbel, Philipp, Andreas Willer, Melanie Kripp, et al.. (2009). Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status. Oncology. 77(5). 293–299. 64 indexed citations

18.

Kripp, Melanie, et al.. (2008). Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. Anti-Cancer Drugs. 20(1). 75–78. 8 indexed citations

19.

Hofheinz, Ralf‐Dieter, Frederik Wenz, Sabine Mai, et al.. (2008). Oxaliplatin and Capecitabine-Based Chemoradiotherapy for Gastric Cancer—An Extended Phase I MARGIT and AIO Trial. International Journal of Radiation Oncology*Biology*Physics. 73(1). 142–147. 16 indexed citations

20.

Ernst, Thomas, Kirsten Merx, Ulrike Gnad-Vogt, et al.. (2007). Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial. British Journal of Cancer. 97(11). 1475–1479. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact